ITI is a program of The Task Force for Global Health.
Zambia began full SAFE implementation for trachoma elimination in 2010 and Zithromax® was approved for trachoma MDAs in four districts. The first major MDA for trachoma elimination also took place in 2012.
The national program convened a stakeholder meeting with implementing partners in February 2016 to finalize survey methodology for mapping districts previously surveyed using non-standard methodology. Prevalence mapping using the Tropical Data platform began in May 2016 in 42 districts and the results indicate that the trachoma burden in Zambia is far less severe than once expected.
MDAs and other aspects of the SAFE strategy have been supported by Sightsavers, Geneva Global, Orbis, Lions Aid Norway and Operation Eyesight Universal with funding from the Department for International Development, UK (DFID) and the Queen Elizabeth Diamond Jubilee Trust.
CURRENT IMPLEMENTATION STATUS
A TAP workshop was organized in February 2017 to prepare a budget and plan for SAFE implementation over the next three years based on new prevalence data.
All 2017 and 2018 MDAs will be supported by Sightsavers with funding and implemented by the national program with support from Lions Aid Norway, Operation Eyesight Universal, and Orbis.
Zithromax® Shipments by Year